Scleroderma epidemiology and demographics

Scleroderma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Scleroderma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Scleroderma epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Scleroderma epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Scleroderma epidemiology and demographics
CDC on Scleroderma epidemiology and demographics
Scleroderma epidemiology and demographics in the news
Blogs on Scleroderma epidemiology and demographics
Directions to Hospitals Treating Scleroderma
Risk calculators and risk factors for Scleroderma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Age

• Juvenile scleroderma affects approximately 7,000 children in the United States.
• The most common form of Juvenile Scleroderma is Localized Scleroderma - Morphea and/or Linear.

Gender

• It is four times as common in women than in men.

Developed Countries

• Incidence rates are estimated at 0.2-2 per 100,000 per year in the United States.